About BioMed Transition Partners

BioMed Transition Partners ("BioMed") and its team of skilled industry operating executives assist investors, boards of directors, and management of biomedical companies by providing guidance, leadership, and, when requested, hands-on management to effect change, stimulate growth, identify and complete transactions, build investor value, enable financings, and facilitate shareholder liquidity.

In concert with company management, BioMed identifies issues that affect the growth and success of a company and creates opportunities not previously available to the company. Working side-by-side with the management team, BioMed develops targeted strategic initiatives and assists in implementing change that produces measurable results. Our activities frequently are directed at identifying and removing obstacles that block a company from obtaining additional funding.

The Partners and affiliated industry executives of BioMed provide investors and boards with an independent strategic view of options available to a company. When requested by investors or boards, the BioMed team can conduct scientific, business, clinical, and operational due diligence of companies, as well as serve as change agents in support of management. The BioMed team can also serve as turnaround and interim management to bolster the value of companies that find themselves in transition.

BioMed is an affiliate of The Channel Group, LLC, a New York-based venture investment, development, and management firm.